Am J Transplant, Volume 20, Suppl 3 Archives - Page 59 of 223 - ATC Abstracts

2020 American Transplant Congress
A Comparison of Kidney Paired Donation Education Delivery Across 68 National Kidney Registry-Affiliated Centers
A. Waterman¹, E. H. Wood¹, O. N. Ranasinghe¹, J. L. Beaumont², S. McGuire³, K. Miller⁴, V. Chipman⁵, J. Sinacore⁶, M. Cooper⁷
¹Division of Nephrology, David Geffen School of Medicine, Los Angeles, CA, ²Terasaki Research Institute, Los Angeles, CA, ³UCLA Kidney and Pancreas Transplant Programs, Los Angeles, CA, ⁴UW Health, Madison, WI, ⁵UCSF Medical Center, San Francisco, CA, ⁶National Kidney Registry, Babylon, NY, ⁷Medstar Georgetown Transplant Institute, Washington, DC
*Purpose: To understand the kidney paired donation (KPD) educational delivery process and variation across centers affiliated with the National Kidney Registry (NKR) we surveyed transplant…
2020 American Transplant Congress
HCV Viremic Kidneys for Uninfected Recipients with DAA Treatment Offers Sustained Virologic Response
J. Torabi, A. Montal, M. Ajaimy, L. Lirano, Y. Azzi, C. Pynadath, E. Akalin, J. Melvin, M. Kinkhabwala, S. Greenstein, J. P. Rocca, J. A. Graham
Montefiore Medical Center, Bronx, NY
*Purpose: Development of direct acting anti-viral medications (DAA) have offered cure rates for hepatitis C infection (HCV) approaching 100%. This has provided the ability to…
2020 American Transplant Congress
Is Bridging Anticoagulation or Antiplatelet Reversal Necessary Prior to Kidney Transplantation?
J. C. Alonso-Escalante, R. P. Tindall, L. Machado, K. R. Tabar, N. Thai, T. Uemura
AHN Transplant Institute, Allegheny General Hospital, Pittsburgh, PA
*Purpose: Pre-kidney transplant patients are often placed on anticoagulation or antiplatelet therapy, and their perioperative management is often challenging. The aim of this study is…
2020 American Transplant Congress
Understanding the Decision-Making of 2576 Potential Living Kidney Donors of Different Racial/Ethnic Backgrounds
A. Waterman¹, G. H. Kim¹, Y. Cui², O. N. Ranasinghe¹, J. L. Beaumont², D. Adey³, U. Reddy⁴, B. Campbell⁵, F. L. Weng⁶
¹Division of Nephrology, David Geffen School of Medicine, Los Angeles, CA, ²Terasaki Research Institute, Los Angeles, CA, ³UCSF Health, San Francisco, CA, ⁴UC Irvine, Irvine, CA, ⁵Cedars Sinai Medical Center, Los Angeles, CA, ⁶St. Barnabas Medical Center, Livingston, NJ
*Purpose: To better understand racial/ethnic disparities associated with kidney living donation, this study examined differences in potential living kidney donors’ decision-making, resistance to donation, and…
2020 American Transplant Congress
Assessment of Time to Therapeutic Tacrolimus Levels Following Renal Transplantation in a Non-Weight-Based Dosing Model
J. Banbury¹, A. Dodson¹, C. Lin², K. Gutierrez¹
¹University of Alabama at Birmingham Hospital, Birmingham, AL, ²Center for Clinical and Translational Science, University of Alabama at Birmingham, Birmingham, AL
*Purpose: The optimal initial dose for tacrolimus (TAC) after renal transplant (RT) remains controversial with limited evidence comparing weight-based and conservative strategies. Recent literature suggests…
2020 American Transplant Congress
Evaluating the Efficacy of Robotic-Assisted Incisional Hernia Repair for Post-Liver Transplant Recipients
G. Rofaiel, G. Pan, M. Goodale, E. Martinez
University of Utah, Salt Lake City, UT
*Purpose: Hernia formation is a well-known complication following open abdominal surgery that contributes to post-operative morbidity and decreases in patient quality of life. Herein we…
2020 American Transplant Congress
Temporal Trends in Utilization and Outcomes of DCD Livers for Liver Transplantation in the United States
K. R. Jackson, J. Motter, A. Massie, B. Philosophe, J. Garonzik-Wang, D. Segev
Johns Hopkins University, Baltimore, MD
*Purpose: Donation after cardiac death (DCD) livers represent a possible expansion to the donor pool, but are frequently discarded due to an increased mortality and…
2020 American Transplant Congress
Effect of 2015 T2 Hepatocellular Carcinoma Exception Policy Implementation on Waitlist Time and Tumor Characteristics
C. Durkin¹, D. E. Kaplan², T. Bittermann²
¹Internal Medicine, University of Pennsylvania, Philadelphia, PA, ²Gastroenterology, University of Pennsylvania, Philadelphia, PA
*Purpose: A United Network for Organ Sharing (UNOS) policy change in 2015 created a 6-month delay in the receipt of T2 hepatocellular carcinoma (HCC) exception…
2020 American Transplant Congress
Impact of Donation after Circulatory Death Allografts on Outcomes Following Liver Re-Transplantation in the United States
S. Kumar¹, S. Lin², J. D. Schold²
¹Digestive Disease Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates, ²Quantitative Health Sciences, Cleveland Clinic Foundation, Cleveland, OH
*Purpose: Scarcity of donor organs in liver transplantation (LT) has necessitated consideration of donation after circulatory death (DCD) donors. Complications following LT and disease recurrence…
2020 American Transplant Congress
Performance Evaluation of the Stanford Integrated Psychosocial Assessment for Transplantation (SIPAT) in Liver Transplant Candidates
P. Gomez, K. Zucker, J. Foote, C. Thomas, R. Anderson, R. Nathan, S. Mehta, N. Patel, M. Fallon, A. Seetharam
University of Arizona College of Medicine Phoenix, Phoenix, AZ
*Purpose: The Stanford Integrated Psychosocial Assessment for Transplantation (SIPAT) tool is employed in candidate evaluation. SIPAT scoring and association with outcomes post liver transplant (LT)…